Skip to content
Subscribe
Newsletter
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Finding a Diagnosis
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Quest Blog
Podcast
Product Guide
Research Advances
Blog Post
Eledon Announces Positive Topline Results from a Phase 2a Study of Tegoprubart to Treat ALS
By
Sujatha Gurunathan
|
June 1, 2022
Featured Article
A Successful In-Person Conference
By
MDA Staff
|
May 13, 2022
Blog Post
Brain-Computer Interface Technology Could Improve Life for Millions
By
Larry Luxner
|
May 9, 2022
FDA Approves Alexion’s Ultomiris for Treatment of gMG
By
Sujatha Gurunathan
|
April 28, 2022
Blog Post
Researchers Announce Results from a Phase 3 Study of Corticosteroid Dosing to Treat DMD
By
Sujatha Gurunathan
|
April 7, 2022
Blog Post
Simply Stated: What is Becker Muscular Dystrophy?
By
Sujatha Gurunathan
|
January 6, 2022
Blog Post
FDA Approves argenx’s Vyvgart for Treatment of gMG
By
Sujatha Gurunathan
|
December 20, 2021
Blog Post
Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD
By
Sujatha Gurunathan
|
September 30, 2021
Featured Article
One in a Million
By
Debra Gordon
|
August 20, 2021
Featured Article
Researchers Want to Know More About Oculopharyngeal Muscular Dystrophy
By
MDA Staff
|
August 20, 2021
« Previous
1
2
3
4
5
6
…
10
Next »
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset